-
Study aim
-
Determining the effect of promethazine prescription on sedation, reducing nausea and quality of upper esophageal and gastric endoscopy
-
Design
-
A randomized clinical trial on 22 patients. Groups include intervention and control groups. Patients will be randomly allocated to the groups using simple randomization method with random number table.
-
Settings and conduct
-
Participants will be selected from patients of Urmia Imam Khomeini endoscopy ward and will be allocated randomly to the intervention and control groups. The intervention group will be given 30 cc of promethazine syrup in 100 cc of drinking water and the control group will be given 50 glucose dissolved in 100 cc of drinking water.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: age between 18 and 40 years, Systolic blood pressure greater than 90 and less than 130 mm Hg, peripheral blood saturation without oxygen more than 95%, no use of sleeping pills, respiratory rate between 12 to 18 times per minute، do not take any drug other than antacids ،willingness to participate in the study.
Exclusion criteria: Presence of diabetes, hypertension, thyroid disease, heart disease, liver disease such as cirrhosis and hepatitis, chronic or acute lung disease, Rheumatologic disease, neurological disease and pregnancy.
-
Intervention groups
-
In the intervention group, 30 cc of promethazine syrup (1mg /cc ) in 100 cc of drinking water made by Emad Darman Pars Pharmaceutical Company will be given to the patient one hour before endoscopy by someone other than the endoscopist. In the control group, 50 g of glucose dissolved in 100 cc of drinking water will be given to the patient one hour before endoscopy.
-
Main outcome variables
-
total procedure time, Patient cooperation , endoscopist satisfaction, patient satisfaction, duration of recovery , complications, patient anxiety, patient level of consciousness